Доступ предоставлен для: Guest
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции
International Journal of Medicinal Mushrooms
Импакт фактор: 1.423 5-летний Импакт фактор: 1.525 SJR: 0.431 SNIP: 0.661 CiteScore™: 1.38

ISSN Печать: 1521-9437
ISSN Онлайн: 1940-4344

Выпуски:
Том 22, 2020 Том 21, 2019 Том 20, 2018 Том 19, 2017 Том 18, 2016 Том 17, 2015 Том 16, 2014 Том 15, 2013 Том 14, 2012 Том 13, 2011 Том 12, 2010 Том 11, 2009 Том 10, 2008 Том 9, 2007 Том 8, 2006 Том 7, 2005 Том 6, 2004 Том 5, 2003 Том 4, 2002 Том 3, 2001 Том 2, 2000 Том 1, 1999

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushrooms.v1.i2.40
pages 147-152

Studies on the Triterpenoid Constituents of the Spores of Ganoderma lucidum (Curt.: Fr.) P. Karst. (Aphyllophoromycetideae)

Ruo-Yun Chen
Department of Chemistry of Natural Products Institute of Materia Medica, Chinese Academy of Medical Science, Beijing, R.P. China
De-Quan Yu
Department of Chemistry of Natural Products, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, 100050, China

Краткое описание

Five compounds were isolated from the ether-soluble fraction of the spores of Ganoderma lucidum (Curt.: Fr.) P. Karst. On the basis of their chemical properties and spectral data (MS, UV, IR, 1H, and 13C-NMR), they were identified as 3,7,11,12,15,23-hexaoxo-5α-lanosta-8-en-26-oic acid (I); ganoderic acids B (II), C (III), and E (IV); and ganodermanontriol (V). Compound I is a new natural product named ganosporeric acid A. Compounds II, III, IV, and V are known compounds and were obtained for the first time from the spores of G. lucidum. Pharmacological experiments showed that ganosporeric acid A has GPT-lowering activity in mice with liver injury caused by CCI4 and GaNI and exhibits hepaoprotective effects.